dsip peptide dose dosing Delta Sleep-Inducing Peptide [DSIP] DSIP

The Phase 2 obesity trial published in the New England Journal of Medicine reported substantial weight reduction over 48 weeks, while a separate Phase 2 trial in people with type 2 diabetes evaluated glycemic and body-weight effects

FIG 14A-D Effect of the HGF antagonist Hinge on HGF- and Dihexa-mediated enhancement of mEPSCs in dissociated hippocampal neurons

Potential Side Effects: Topical applications may cause mild skin irritation in sensitive individuals

Words may be horizontal or vertical and may run backwards

(Diabetes Obes Metab 2024) found no clinically relevant QTc prolongation

Measure Use vial concentration and U-100 syringe units to draw small volumes accurately